Aquila Diagnostics Inc. is focused on the commercialization of a proprietary nucleic acid-based point-of-care rapid diagnostic tests for the detection of infectious pathogens and genetic markers. Our technology platform is a low cost, portable device with accompanying disposables that allows for low cost, accurate and timely detection of multiple targets in microliter volumes of biofluids at the point of care or need.